Michał Malesza

Dr. Michał Malesza

Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, Poland
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2021 in Cells
Verified
Journal Article
Open access
PDF file
IMIda Judyta Malesza
Ida Judyta Malesza
MMMichał Malesza
Michał Malesza
JWJarosław Walkowiak
Jarosław Walkowiak
NMNadiar Mussin
Nadiar Mussin
DWDariusz Walkowiak
Dariusz Walkowiak
Edyta MądryEdyta Mądry
Edyta Mądry
The gut microbiota is responsible for recovering energy from food, providing hosts with vitamins, and providing a barrier function against exogenous pathogens. In addition, it is involved in maintaining the integrity of the intestinal epithelial barrier, crucial for the functional maturation of the gut immune system. The Western diet (WD)—an unhealthy diet with high consumption of fats—can be broadly characterized by overeating, frequent snacking, and a prolonged postprandial state. The term WD is commonly known and intuitively understood. However, the strict digital expression of nutrient ratios is not precisely defined. Based on the US data for 1908–1989, the calory intake available from fats increased from 32% to 45%. Besides the metabolic aspects (hyperinsulinemia, insulin resistance, dyslipidemia, sympathetic nervous system and renin-angiotensin system overstimulation, and oxidative stress), the consequences of excessive fat consumption (high-fat diet—HFD) comprise dysbiosis, gut barrier dysfunction, increased intestinal permeability, and leakage of toxic bacterial metabolites into the circulation. These can strongly contribute to the development of low-grade systemic inflammation. This narrative review highlights the most important recent advances linking HFD-driven dysbiosis and HFD-related inflammation, presents the pathomechanisms for these phenomena, and examines the possible causative relationship between pro-inflammatory status and gut microbiota changes.

29 January 2020 in Molecular and Cellular Biochemistry
Verified
Journal Article
Open access
PDF file
BSBartosz Kazimierz Słowikowski
Bartosz Kazimierz Słowikowski
HDHanna Drzewiecka
Hanna Drzewiecka
MMMichał Malesza
Michał Malesza
IMIda Mądry
Ida Mądry
KSKarolina Sterzyńska
Karolina Sterzyńska
PJPaweł Piotr Jagodziński
Paweł Piotr Jagodziński
In recent years, peroxisome proliferator-activated receptor-γ (PPARγ) has been intensively studied. Because its activation is often associated with changes in the expression level of various apoptotic genes, many studies have emphasized the role of PPARγ as an important anticancer agent. However, in different types of cancer, different genes are influenced by PPARγ action. Previous studies showed that conjugated linoleic acid (CLA) was able to induce apoptosis, upregulate PPARG gene expression and activate PPARγ protein in certain human cancer cell lines. Moreover, some PPARγ agonists inhibited the growth of human lung cancer cells through the induction of apoptosis. Nevertheless, the impact of CLA on PPARγ mRNA and protein levels in non-small cell lung cancer (NSCLC) cell lines has not been investigated thus far. Therefore, in our study, we analysed the influence of the c9,t11 linoleic acid isomer on the expression of PPARG and other genes involved in the apoptotic response (BCL-2, BAX, and CDKN1A) in two NSCLC cell lines of different histological origin (A549 and Calu-1) and in normal human bronchial epithelial Beas-2B cells. Cells were treated with several doses of c9,t11 CLA, followed by RNA and protein isolation, cDNA synthesis, real-time quantitative PCR (RT-qPCR) and Western blot analysis. We showed that the investigated CLA isomer was able to enhance the expression of PPARγ in the examined cell lines and alter the mRNA and protein levels of genes involved in apoptosis. Fluorescent staining and MMT assay revealed the antiproliferative potential of CLA as well as its ability to activate pathways that lead to cell death.

Verified
Journal Article
Open access
PDF file
IMIda Judyta Malesza
Ida Judyta Malesza
MMMichał Malesza
Michał Malesza
IKIwona Krela-Kaźmierczak
Iwona Krela-Kaźmierczak
AZAleksandra Zielińska
Aleksandra Zielińska
Eliana B. SoutoEliana B. Souto
Eliana B. Souto
Piotr EderPiotr Eder
Piotr Eder
In recent years, the incidence of immune-mediated gastrointestinal disorders, including celiac disease (CeD) and inflammatory bowel disease (IBD), is increasingly growing worldwide. This generates a need to elucidate the conditions that may compromise the diagnosis and treatment of such gastrointestinal disorders. It is well established that primary immunodeficiencies (PIDs) exhibit gastrointestinal manifestations and mimic other diseases, including CeD and IBD. PIDs are often considered pediatric ailments, whereas between 25 and 45% of PIDs are diagnosed in adults. The most common PIDs in adults are the selective immunoglobulin A deficiency (SIgAD) and the common variable immunodeficiency (CVID). A trend to autoimmunity occurs, while gastrointestinal disorders are common in both diseases. Besides, the occurrence of CeD and IBD in SIgAD/CVID patients is significantly higher than in the general population. However, some differences concerning diagnostics and management between enteropathy/colitis in PIDs, as compared to idiopathic forms of CeD/IBD, have been described. There is an ongoing discussion whether CeD and IBD in CVID patients should be considered a true CeD and IBD or just CeD-like and IBD-like diseases. This review addresses the current state of the art of the most common primary immunodeficiencies in adults and co-occurring CeD and IBD.

1 August 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
Joanna Bartkowiak-WieczorekJoanna Bartkowiak-Wieczorek
Joanna Bartkowiak-Wieczorek
MMMichał Malesza
Michał Malesza
IMIda Judyta Malesza
Ida Judyta Malesza
THTomasz Hadada
Tomasz Hadada
JWJakub Jan Winkler-Galicki
Jakub Jan Winkler-Galicki
Edyta MądryEdyta Mądry
Edyta Mądry
Methylsulfinyl hexyl isothiocyanate (6-MSITC) isolated from Eutrema japonicum is a promising candidate for the treatment of breast cancer, colorectal and stomach cancer, metabolic syndrome, heart diseases, diabetes, and obesity due to its anti-inflammatory and antioxidant properties. Also, its neuroprotective properties, improving cognitive function and protecting dopaminergic neurons, make it an excellent candidate for treating neurodegenerative diseases like dementia, Alzheimer’s, and Parkinson’s disease. 6-MSITC acts on many signaling pathways, such as PPAR, AMPK, PI3K/AKT/mTOR, Nrf2/Keap1-ARE, ERK1/2-ELK1/CHOP/DR5, and MAPK. However, despite the very promising results of in vitro and in vivo animal studies and a few human studies, the molecule has not yet been thoroughly tested in the human population. Nonetheless, wasabi should be classified as a “superfood” for the primary and secondary prevention of human diseases. This article reviews the current state-of-the-art research on 6-MSITC and its potential clinical uses, discussing in detail the signaling pathways activated by the molecule and their interactions.

1 March 2018 in International Surgery
Verified
Journal Article
Closed access
ICIzabela Chudzicka-Strugała
Izabela Chudzicka-Strugała
IMIda Judyta Mądry
Ida Judyta Mądry
MMMichał Malesza
Michał Malesza
AKAij Lie Kwan
Aij Lie Kwan
WWWilliam Winardi
William Winardi
Edyta MądryEdyta Mądry
Edyta Mądry
Objective: Demodex is the most common external human parasite. It has been suggested that the Demodex infection may be associated with malnutrition, nutritional deficiencies, reduced immunity, and poor hygiene. The patients who benefitted from humanitarian aid in Indonesia, often demonstrated the abovementioned risk factors. The aim of the present report was to assess the prevalence of Demodex infestation in ophthalmic patients in Indonesian.Patients and methods: A total of 217 individuals (132 women) with ocular discomfort, who presented to the ophthalmologist in mission points in Indonesia (Bali, Java, and Papua, the province of Indonesia in the New Guinea Island) were checked for the presence of Demodex on their eyelashes and underwent an anthropometric examination.Results: The prevalence of ocular demodicosis varies from 71.2% in Bali to 89.2% in Papua. There were no statistically significant differences between the islands, urban or rural areas, or between sexes. A statistically significant difference was found between nutritional status and Demodex infestation (P = 0.0007). Malnourished and overweight patients had odds of being infested with Demodex that were approximately 8 and 3 times higher, respectively, compared with subjects with a normal body mass index.Conclusions: Ocular demodicosis is very common in medically underserved areas of Bali, Java, and Papua, where it exceeds the frequency observed in countries of the northern hemisphere. An abnormal nutritional status comprising of both malnutrition and being overweight appears to be a risk factor for Demodex infection. This issue requires further research.

2 August 2020
Verified
Preprint
Open access
MMMichał Malesza
Michał Malesza
IMIda Malesza
Ida Malesza
IKIwona Krela-Kaźmierczak
Iwona Krela-Kaźmierczak
AZAleksandra Zielińska
Aleksandra Zielińska
Eliana B. SoutoEliana B. Souto
Eliana B. Souto
Piotr EderPiotr Eder
Piotr Eder
In recent years, the incidence of immune-mediated gastrointestinal disorders, including celiac disease (CeD) and inflammatory bowel disease (IBD), is increasingly growing worldwide. It is well established that primary immunodeficiencies (PIDs) exhibit gastrointestinal manifestations and mimic other diseases, including CeD and IBD. The most common PIDs in adults are the selective immunoglobulin A deficiency (SIgAD) and the common variable immunodeficiency (CVID). However, some differences concerning diagnostics and management between enteropathy/colitis in PIDs, as compared to idiopathic forms of CeD/IBD, have been described. There is an ongoing discussion whether CeD and IBD in CVID patients should be considered a true CeD and IBD or just CeD-like and IBD-like diseases. This review addresses the current state of the art of the most common primary immunodeficiencies in adults and co-occurring CeD and IBD.